Tissue localization of toll-like receptors in biopsy specimens of liver from children infected with hepatitis C virus

Scandinavian Journal of Immunology

Volumn 62, Issue 4, 2005, Pages 407-412

  Mozer Lisewska, I ^a   Sluzewski, W ^a   Kaczmarek, M ^a   Jenek, R ^a   Szczepanski, M ^a   Figlerowicz, M ^a   Kowala Piaskowska, A ^a   Zeromski, J ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4;

ARTICLE; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL; MOLECULAR DYNAMICS; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ADOLESCENT; CHILD; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 27644497520     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2005.01670.x     Document Type: Article

References (15)

1. Davis GL. Current therapy for chronic hepatitis C. Gastroenterology 2000;118:104-14.
2. Freeman AJ, Marines G, Ffrench RA et al. Immunopathogenesis Hepatitis C Infection. Immunol Cell Biol 2001;79:515-36.
3. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135-45.
4. Akira S. Toll-like receptors and innate immunity. Adv Immunol 2001;78:1-56.
5. Liu S, Gallo DJ, Green AM et al. Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun 2002;70:3433-42.
6. Isogawa M, Robek MD, Furuichi Y et al. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 2005;79:7269-72.
7. Lien E, Ingalls RR. Toll-like receptors. Grit Care Med 2002;30 (Suppl. 1-10):S1-S11.
8. Nishimura M, Naito S. Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol Pharm Bull 2005;28:886-92.
9. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000;68:7010-7.
10. Hornef MF, Frisan T, Vandewalle A et al. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccaride in intestinal epithelial cells. J Exp Med 2002;195:559-70.
11. Pivarsci A, Bodai L, Rethi B et al. Expression and function of toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 2003;15:721-30.
12. Dolganiuc A, Oak S, Kodys K et al. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 2004;127:1513-24.
13. Manigold T, Bocker U, Hanck C et al. Differential expression of toll-like receptors 2 and 4 in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2003;15:275-82.
14. Takii Y, Nakamura M, Ito M et al. Enhanced expression of type I interferon and toll-like receptor 3 in primary biliary cirrhosis. Lab Invest 2005;85:908-20.
15. Iredale JP. Regulating hepatic inflammation: pathogen-associated molecular patterns take their toll. Hepatology 2003;37:979-82.